Houston Methodist shares the news made by our clinician scientists, researchers, innovators and faculty, beginning in 2020.
Anatomic Aligner Cleared by FDA
March 16 - Houston Methodist recently reached a major milestone, receiving U.S. Food and Drug Administration (FDA) 510(k) clearance to market the AnatomicAligner, a novel software program used to improve planning for craniomaxillofacial (CMF) surgeries.
Setting A Record: 525 Transplants in 2019
March 9 - Houston Methodist J.C. Walter Jr. Transplant Center performed 525 transplants—the most in its more than 50-year history, which performed the world's first multi-organ transplant in 1968.
Discovery May Lengthen Survival of Transplants
May 8 - Xian Chang Li, MD, PhD, Max and Lillie Frosch Centennial Chair in Transplant Research, is co-author of a study in June’s Science, suggesting the immune system can remember foreign cells, paving the way for drugs that lengthen survival of transplanted organs.
Mitra Sankar PNAS
National Academy of Sciences Features Mitra Study
Aug. 21, 2020 -  Sankar Mitra, PhD, emeritus professor of oncology, Houston Methodist Cancer Center, and colleagues' work is featured in The Proceedings of the National Academy of Sciences. The study underscores that endogenous genome damage is grossly underestimated, and highlights orchestration of continuous damage induction and repair in the human body.
Underwood IBS trial
Underwood is Primary Center in IBS Clinical Trial
June 1, 2020 -  The Lynda K. and David M. Underwood Center for Digestive Disorders is a primary enrollment center in a clinical trial for Biomerica’s InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy, which may enable physicians to identify patient-specific foods that, when removed, may alleviate a patient's IBS symptoms.
Copyright 2020. Houston Methodist, Houston, TX. All rights reserved. Privacy & Disclaimer | Sign Up for Our Monthly Newsletter | Browse the Archive